Finance

Lists
Why is TNON down 4,55%?
Dive Deeper
TNON:NASDAQ
Tenon Medical Inc
USD 2,73
-4,55%
(-0,13) 1D
USD 2,73
0,00% (0,00)
Pre-market
Closed: 29 Sep., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TNON...
Open
USD 2,80
High
USD 2,88
Low
USD 2,67
Mkt. cap
2,82 m
Avg. vol.
11,52 m
Volume
4,51 k
52-wk high
USD 50,40
52-wk low
USD 2,40
EPS
-USD 47,43
Beta
1,36
Shares outstanding
1,03 m
No. of employees
26
Open
USD 2,80
High
USD 2,88
Low
USD 2,67
Mkt. cap
2,82 m
Avg. vol.
11,52 m
Volume
4,51 k
52-wk high
USD 50,40
52-wk low
USD 2,40
EPS
-USD 47,43
Beta
1,36
Shares outstanding
1,03 m
No. of employees
26
About Tenon Medical Inc
CEO-
Employees26
Founded2012
HeadquartersLos Gatos, Kalifornië, Verenigde State van Amerika
SectorMedical device
Analyst ratings
Based on 1 analyst giving stock ratings to TNON in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for TNON in the last 3 months
Highest
Current USD 2,73
USD 10,00 (+266,30%)
Average
USD 10,00 (+266,30%)
Lowest
USD 10,00 (+266,30%)
Analyst
Recommendation
Action
Price target
Projected
Date
Anthony Vendetti
Maxim Group
Buy
Reiterated
USD 10,00
+266,3%
08/17/2026
Scott Henry
Alliance Global Partners
Buy
Maintained
USD 2,25
-17,6%
05/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,17 m
1,48 m
1,38 m
1,28 m
Cost of goods sold
400,00 k
464,00 k
434,00 k
465,00 k
Cost of revenue
400,00 k
464,00 k
434,00 k
465,00 k
Research and development expenses
428,00 k
527,00 k
662,00 k
768,00 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,96 m
3,36 m
3,56 m
3,40 m
Operating expense
3,39 m
3,88 m
4,22 m
4,17 m
Total operating expenses
3,79 m
4,35 m
4,66 m
4,63 m
Operating income
-2,61 m
-2,87 m
-3,28 m
-3,35 m
Other non operating income
-
-
-45,00 k
132,00 k
EBT including unusual items
-3,34 m
-2,83 m
-3,48 m
-4,05 m
EBT excluding unusual items
-2,56 m
-2,83 m
-3,48 m
-4,05 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,34 m
-2,83 m
-3,48 m
-4,05 m
Net profit margin
-284,65%
-191,22%
-252,07%
-316,65%
Earnings per share
-14,00
-7,70
-10,85
-12,35
Interest and investment income
53,00 k
34,00 k
25,00 k
24,00 k
Interest expense
-
-
-176,00 k
-852,00 k
Net interest expenses
53,00 k
34,00 k
-151,00 k
-828,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,54 m
-2,78 m
-3,19 m
-3,29 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme